These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6106684)

  • 1. Synthesis and pharmacological properties of N-[4-(1-azetidinyl)-2-butynyl]-2-pyrrolidone, a highly potent oxotremorine-like agent.
    Resul B; Lewander T; Zetterström T; Ringdahl B; Muhi-Eldeen Z; Dahlbom R
    J Pharm Pharmacol; 1980 Jun; 32(6):439-40. PubMed ID: 6106684
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.
    Svensson U; Hacksell U; Dahlbom R
    Acta Pharm Suec; 1978; 15(1):67-70. PubMed ID: 645369
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological properties of oxotremorine and its analogs.
    Ringdahl B; Jenden DJ
    Life Sci; 1983 May; 32(21):2401-13. PubMed ID: 6343743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones.
    Amstutz R; Ringdahl B; Karlén B; Roch M; Jenden DJ
    J Med Chem; 1985 Dec; 28(12):1760-5. PubMed ID: 2933518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.
    Nilsson BM; Vargas HM; Ringdahl B; Hacksell U
    J Med Chem; 1992 Jan; 35(2):285-94. PubMed ID: 1732545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in central and peripheral responses to oxotremorine in young and aged rats.
    Espínola EB; Oliveira MG; Carlini EA
    Pharmacol Biochem Behav; 1999 Mar; 62(3):419-23. PubMed ID: 10080232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.
    Murugaiah KD; Ukponmwan OE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):294-300. PubMed ID: 13680087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity of some oxotremorine antagonists containing two chiral centres.
    Ringdahl B; Resul B; Dahlbom R
    J Pharm Pharmacol; 1979 Dec; 31(12):837-9. PubMed ID: 43369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B; Resul B; Ehlert FJ; Jenden DJ; Dahlbom R
    Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor.
    Wang N; Orr-Urtreger A; Chapman J; Rabinowitz R; Korczyn AD
    J Neurol Sci; 2004 Jul; 222(1-2):87-91. PubMed ID: 15240201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylene compounds of potential pharmacological value. XXVIII. Oxotremorine analogues substituted with a methyl group in the lactam ring.
    Ringdahl B; Muhi-Eldeen Z; Ljunggren C; Karlén B; Resul B; Dahlbom R
    Acta Pharm Suec; 1979; 16(2):89-94. PubMed ID: 474169
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine.
    Dahlbom R; Jenden DJ; Resul B; Ringdahl B
    Br J Pharmacol; 1982 Jun; 76(2):299-304. PubMed ID: 7093587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
    Grauer E; Levy A
    Toxicology; 2007 Dec; 242(1-3):1-6. PubMed ID: 17931764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevance.
    Inch TD; Green DM; Thompson PB
    J Pharm Pharmacol; 1973 May; 25(5):359-70. PubMed ID: 4146390
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison in the mouse of the peripheral and central cholinergic or anticholingergic properties of some structural analogues of oxotremorine (oxo-2 pyrrolidino-1)-1 (pyrrolidino-1)-4 butyne-2].
    Lévy J; Michel-Ber E
    C R Acad Hebd Seances Acad Sci D; 1967 May; 264(18):2250-3. PubMed ID: 4963416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.